-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
pEBOV-IN-1
Category | Filovirus |
CAS | 1252187-41-9 |
Description | 3-Phenyl-N-[1-(phenylmethyl)-4-piperidinyl]tricyclo[3.3.1.13,7]decane-1-carboxamide has antiviral activity against Ebola virus, targeting surface-exposed glycoproteins and inhibiting viral entry into host cells. It inhibits viral replication with an EC50 of 0.38 μM. |
Product Information
Synonyms | 1252187-41-9;N-(1-benzylpiperidin-4-yl)-3-phenyladamantane-1-carboxamide;pEBOV-IN-1;3-Phenyl-N-[1-(phenylmethyl)-4-piperidinyl]-tricyclo[3.3.1.13,7]decane-1-carboxamide;CHEMBL4639565;SCHEMBL19172947;AKOS034528023;PD158746;TS-09813;HY-139223;CS-0182103;Z68297480; |
IUPAC Name | N-(1-benzylpiperidin-4-yl)-3-phenyladamantane-1-carboxamide |
Molecular Weight | 428.61 |
Molecular Formula | C29H36N2O |
Canonical SMILES | O=C([C@@]12C[C@@](C[C@@H]3C2)(C4=CC=CC=C4)C[C@H](C3)C1)NC(CC5)CCN5CC6=CC=CC=C6 |
InChI | InChI=1S/C29H36N2O/c32-27(30-26-11-13-31(14-12-26)20-22-7-3-1-4-8-22)29-18-23-15-24(19-29)17-28(16-23,21-29)25-9-5-2-6-10-25/h1-10,23-24,26H,11-21H2,(H,30,32) |
InChIKey | OLLXRRVKVDQNML-UHFFFAOYSA-N |
Boiling Point | 600.4±54.0°C at 760 mmHg |
Purity | ≥95% |
Density | 1.17±0.1 g/cm3 |
Solubility | Soluble in DMSO |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |